March 27 (Reuters) - Boundless Bio Inc BOLD.O:
BOUNDLESS BIO REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
BOUNDLESS BIO INC: QTRLY LOSS PER SHARE $0.74
Source text: ID:nGNX31kbGq
Further company coverage: BOLD.O
((Reuters.Briefs@thomsonreuters.com;))